Xylem (NYSE:XYL – Get Free Report) is expected to be announcing its Q2 2026 results before the market opens on Tuesday, July 28th. Analysts expect the company to announce earnings of $1.34 per share and revenue of $2.3415 billion for the quarter. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Individuals may visit the the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Tuesday, July 28, 2026 at 9:00 AM ET.
Xylem (NYSE:XYL – Get Free Report) last posted its quarterly earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, beating the consensus estimate of $1.09 by $0.03. The business had revenue of $2.12 billion during the quarter, compared to analysts’ expectations of $2.11 billion. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The business’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.03 EPS. On average, analysts expect Xylem to post $6 EPS for the current fiscal year and $6 EPS for the next fiscal year.
Xylem Stock Down 0.1%
XYL stock opened at $119.66 on Monday. Xylem has a one year low of $105.29 and a one year high of $154.27. The firm has a market cap of $28.44 billion, a PE ratio of 29.77, a PEG ratio of 1.70 and a beta of 1.03. The firm’s 50 day moving average price is $114.04 and its 200-day moving average price is $122.70. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46.
Xylem Announces Dividend
Insider Buying and Selling at Xylem
In other news, Director Jerome A. Peribere bought 1,210 shares of the firm’s stock in a transaction that occurred on Monday, May 4th. The shares were purchased at an average price of $116.61 per share, with a total value of $141,098.10. Following the purchase, the director owned 27,209 shares in the company, valued at approximately $3,172,841.49. The trade was a 4.65% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the firm’s stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $117.46, for a total value of $501,436.74. Following the transaction, the chief accounting officer owned 3,605 shares of the company’s stock, valued at $423,443.30. This trade represents a 54.22% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 0.32% of the company’s stock.
Institutional Trading of Xylem
Several hedge funds have recently made changes to their positions in the business. AQR Capital Management LLC boosted its stake in shares of Xylem by 14.4% in the first quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company’s stock valued at $3,645,000 after purchasing an additional 3,900 shares during the period. NewEdge Advisors LLC lifted its holdings in Xylem by 3.3% during the 1st quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company’s stock worth $496,000 after buying an additional 132 shares in the last quarter. Empowered Funds LLC boosted its position in Xylem by 56.1% in the 1st quarter. Empowered Funds LLC now owns 8,678 shares of the industrial products company’s stock valued at $1,037,000 after buying an additional 3,120 shares during the period. Arrowstreet Capital Limited Partnership boosted its position in Xylem by 97.6% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 11,151 shares of the industrial products company’s stock valued at $1,442,000 after buying an additional 5,509 shares during the period. Finally, EverSource Wealth Advisors LLC grew its stake in shares of Xylem by 114.0% in the second quarter. EverSource Wealth Advisors LLC now owns 1,192 shares of the industrial products company’s stock worth $154,000 after acquiring an additional 635 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research firms have commented on XYL. UBS Group lifted their target price on Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a research report on Wednesday, April 29th. Oppenheimer cut their price objective on Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a research report on Wednesday, April 29th. JPMorgan Chase & Co. reduced their price objective on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating on the stock in a report on Thursday, April 16th. Citigroup decreased their target price on shares of Xylem from $174.00 to $168.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Finally, Jefferies Financial Group raised shares of Xylem from a “hold” rating to a “buy” rating and increased their target price for the stock from $130.00 to $140.00 in a research note on Thursday, June 25th. Eight investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $153.15.
Get Our Latest Research Report on XYL
About Xylem
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Featured Stories
- Five stocks we like better than Xylem
- RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
- These 4 Earnings Reports Expose the Market’s Growing Economic Divide
- Broadcom May Be the Biggest Winner From Alphabet’s Earnings
- Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
